leader: biomarker analyses of lenvatinib plus eribulin for sarcoma
Published 2 years ago • 138 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
1:26
next steps for leader trial: lenvatinib plus eribulin for sarcoma
-
1:17
elucidating novel biomarkers in osteosarcoma and ewing sarcoma
-
1:42
ask ruby: what is biomarker testing?
-
1:41
differences in soft tissue sarcoma incidences and clinical characteristics between france and taiwan
-
1:38
optimizing biomarker testing to steer treatment decisions
-
1:15
dll3, a new biomarker for neuroendocrine tumors of the lung
-
1:36
defi: nirogacestat demonstrates improved pfs and orr in progressing desmoid tumors
-
2:10
what is a biomarker?
-
1:44
efficacy and biomarker results for pembrolizumab in soft tissue and bone sarcomas
-
1:08
the role of molecular biomarkers in determining patient response to bladder cancer treatment
-
0:31
what is a biomarker?
-
1:35
the lume bionis trial: an exploratory study into lung cancer biomarkers
-
15:09
'aberrant b cell responses in copd' - dr mahdvi menon - lbiii symposium
-
18:36
sofia michopolou: biomarker research to assess inflammation in neurodegeneration using ai
-
7:01
eribulin in advanced soft tissue sarcoma
-
2:13
simple blood test can accurately predict neuroendocrine tumor response to radiopharmaceuticaltherapy
-
1:00
dr. cohen on biomarker testing in head and neck cancer
-
58:57
navigating the complexities of biomarker testing in the expanding field of precision immuno-oncology
-
2:08
clear: lenvatinib and pembrolizumab efficacy in arcc across baseline tumor sizes